Literature DB >> 10352099

Stimulation of osteoblast proliferation by C-terminal fragments of parathyroid hormone-related protein.

J Cornish1, K E Callon, C Lin, C Xiao, J M Moseley, I R Reid.   

Abstract

Parathyroid hormone (PTH)-related protein (107-139) (PTHrP(107-139)) and PTHrP(107-111) have been reported to be potent inhibitors of isolated osteoclast activity, and inhibition of bone resorption by PTHrP(107-139) occurs in vivo. However, the actions of C-terminal PTHrP on osteoblast activity has not been studied much. The present study addresses this issue by examining the effect of PTHrP(107-139), PTHrP(107-119), PTHrP(120-139), and PTHrP(107-111) on the proliferation of fetal rat osteoblasts. Treatment with PTHrP(107-139) for 24 h caused a dose-dependent increase in cell number, [3H]thymidine and [3H]phenylalanine incorporation in cultured osteoblasts. The effect was apparent at concentrations of 10-10 M and greater and was sustained over time. PTHrP(107-119) and PTHrP(107-111) had effects on cell number, DNA, and protein synthesis which were comparable to those of PTHrP(107-139), whereas PTHrP(120-139) was without effect. Retroverted PTHrP(107-111) also stimulated all three activities but was only one tenth as potent as PTHrP(107-139). PTHrP(107-139) had no effect on osteoblast apoptosis. It is concluded that PTHrP(107-139) is not only an inhibitor of osteoclastic bone resorption but that it also stimulates osteoblast growth. This activity resides within the pentapeptide fragment PTHrP(107-111). These findings support a possible role for C-terminal fragments of PTHrP in the normal regulation of bone cell function and, possibly, bone mass.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352099     DOI: 10.1359/jbmr.1999.14.6.915

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

Review 1.  Parathyroid hormone-related protein.

Authors:  R A Nissenson
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Characterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide107-139 as a substrate and osteocalcin, PPi and phosphate as inhibitors.

Authors:  G Boileau; H S Tenenhouse; L Desgroseillers; P Crine
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

3.  PTHrP 1-141 and 1-86 increase in vitro bone formation.

Authors:  Blake Eason Hildreth; Jillian L Werbeck; Nandu K Thudi; Xiyun Deng; Thomas J Rosol; Ramiro E Toribio
Journal:  J Surg Res       Date:  2010-03-16       Impact factor: 2.192

4.  The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia.

Authors:  D Lozano; L Fernández-de-Castro; S Portal-Núñez; A López-Herradón; S Dapía; E Gómez-Barrena; P Esbrit
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 5.  Mechanisms balancing skeletal matrix synthesis and degradation.

Authors:  Harry C Blair; Mone Zaidi; Paul H Schlesinger
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

6.  Osteostatin potentiates the bioactivity of mesoporous glass scaffolds containing Zn2+ ions in human mesenchymal stem cells.

Authors:  C Heras; S Sanchez-Salcedo; D Lozano; J Peña; P Esbrit; M Vallet-Regi; A J Salinas
Journal:  Acta Biomater       Date:  2019-03-16       Impact factor: 8.947

7.  Nanoparticles to Knockdown Osteoporosis-Related Gene and Promote Osteogenic Marker Expression for Osteoporosis Treatment.

Authors:  Patricia Mora-Raimundo; Daniel Lozano; Miguel Manzano; María Vallet-Regí
Journal:  ACS Nano       Date:  2019-05-13       Impact factor: 15.881

8.  Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1.

Authors:  Lidia Ibáñez; Josep Nácher-Juan; María Carmen Terencio; María Luisa Ferrándiz; María José Alcaraz
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

9.  Hard tissue formation after direct pulp capping with osteostatin and MTA in vivo.

Authors:  Ji-Hye Yoon; Sung-Hyeon Choi; Jeong-Tae Koh; Bin-Na Lee; Hoon-Sang Chang; In-Nam Hwang; Won-Mann Oh; Yun-Chan Hwang
Journal:  Restor Dent Endod       Date:  2021-02-25

10.  Osteogenic Effect of ZnO-Mesoporous Glasses Loaded with Osteostatin.

Authors:  Rebeca Pérez; Sandra Sanchez-Salcedo; Daniel Lozano; Clara Heras; Pedro Esbrit; María Vallet-Regí; Antonio J Salinas
Journal:  Nanomaterials (Basel)       Date:  2018-08-04       Impact factor: 5.076

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.